| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_828caa073d7b04d9f6d710c3c8731560 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebce1305c41e377ed67d384d2a816ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f6b89d046b584bfce5864155abed27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63f80c7ec8f7d05a90a55cc760ec5231 |
| publicationDate |
2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110117324-A |
| titleOfInvention |
Antitumor active polypeptide and use thereof |
| abstract |
The present invention relates to an antitumor active polypeptide and its use. The polypeptide has antitumor activity due to having one of the following amino acid sequences: IGLKRTPMGIV, wherein T is modified by phosphorylation. The polypeptide can be used for preparing antitumor drugs. The polypeptide sequence of the present invention is short, and it is easy to realize large-scale production; it shows significant anti-tumor activity at a lower dose. The polypeptide of the present invention has no toxicity to normal tissue cells and has broad application prospects. |
| priorityDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |